Jak2 inhibitor (Cloud Pharmaceuticals/University of Florida)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameJak2 inhibitor (Cloud Pharmaceuticals/University of Florida)
Drug Alias NameJak2 inhibitor (TeraDiscoveries/University of Florida)G-6NB-15
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsTyrosine-protein kinase JAK2 inhibitors
TargetsTyrosine-protein kinase JAK2
Therapy Area/IndicationsHematologic DiseasesGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCloud Pharmaceuticals IncUniversity Of Florida
Active IndicationsN/A
Inactive IndicationsHematologic DiseasesGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A